Skip to main content
OpenTrials
Completed

NCT Number: NCT00530374

Impact of Sprinkles on Infectious Morbidity When Moderate to Severe Pediatric Malnutrition Is Highly Prevalent

The purpose of this study is to determine the safety profile of oral iron supplementation (OIS) with Sprinkles in a pediatric population with high prevalence of Iron deficiency (ID) and moderate or severe malnutrition (MSM); the efficacy profile will also be investigated.

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 year–2 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Village of Shombhuganj

Shombhuganj, Mymensingh District, Bangladesh

About this study

Iron deficiency (ID) affects many children in developing countries. Anemia and impaired brain development are its most significant consequences. These may be prevented by giving oral iron supplements (OIS), such as Sprinkles. ID treatment was controversial because high dose parenteral iron therapy is strongly associated with severe infections when given to severely malnourished children. Many studies have since demonstrated the safety of low dose OIS. WHO guidelines reflect this finding: population-wide iron supplementation campaign (PWISC), without prior screening, is recommended when ID prevalence is ≥ 40%.

However, a gap in the safety evidence has been identified: children with moderate or severe malnutrition (MSM) are strikingly absent from the studies performed to date to investigate the link between OIS and infectious morbidities. In this context, PWISC may have unrecognized deleterious effects when the prevalence of MSM is high, since safety is assumed, but incorrectly extrapolated from available evidence.

We wish to emphasize an additional concern with regards to safety studies published thus far: all were designed as superiority trials. In this context, it is statistically incorrect to conclude that failure to show a significant difference between iron and placebo means that their respective side-effect profiles are similar.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • children aged 12 - 24 months
  • moderate to severe malnutrition (MSM), defined as weight-for-age Z-score ≤ -2 based on the National Center for Health Statistics (NCHS) standards

Exclusion criteria

  • severe anemia (hemoglobin ≤70g/L)
  • near normal hemoglobin concentration (>100g/L)
  • weight-for-height <-3 z-score (severe wasting)
  • kwashiorkor (defined as evidence of edema)
  • congenital abnormality or disease
  • treatment with iron supplements in the past 3 months
  • inclusion in a nutrition program in the past
  • chronic illness other than malnutrition.

Treatment and study plan

Oral iron supplement

Dietary Supplement

Iron Sprinkles are provided as a powder in a single-dose sachet to be taken once daily for 60 days

Other names: Sprinkles

Placebo

Dietary Supplement

Placebo Sprinkles are provided as a powder in a single-dose sachet to be taken once daily for 60 days

Other names: Placebo Sprinkles

Primary outcomes

  1. A composite score based on the sum of all distinct episodes of diarrhea, dysentery and lower respiratory tract infections

    Time frame: 2 distinct and consecutive phases of 6 months each

Secondary outcomes

  1. Incidence of death and fever without a source [Safety]

    Time frame: 2 distinct and consecutive phases of 6 months each

  2. Change in haemoglobin concentration after Sprinkles supplementation [Efficacy]

    Time frame: 2 distinct and consecutive phases of 6 months each

Sponsors and collaborators

Lead sponsor

The Hospital for Sick Children

Other

Collaborators

  • Bangladesh Rural Advancement Committee
  • International Centre for Diarrhoeal Disease Research, Bangladesh

Registry information

Official study title

Impact of Oral Iron Supplementation With Sprinkles on Infectious Morbidity When Moderate to Severe Pediatric Malnutrition Is Highly Prevalent - A Non-Inferiority Safety Trial

Important dates

Study start
2007
Primary completion
2009
Study completion
2009
First posted
Sep 17, 2007
Registry last updated
Apr 19, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.